Outcome Research of a European Registry Platform on Real-world Treatment Data of Patients with Advanced NMSC
Recruiting
- Conditions
- Cutaneous Squamous Cell CarcinomaBasal Cell Carcinoma
- First Posted Date
- 2023-02-23
- Last Posted Date
- 2025-03-12
- Lead Sponsor
- EuMelaReg gGmbH
- Target Recruit Count
- 1300
- Registration Number
- NCT05741073
- Locations
- 🇧🇪
UZ (Universitair Ziekenhuis) Brüssel, Brussels, Belgium
BRAF-/MEK-Inhibition With Dabrafenib and Trametinib in Melanoma Patients
Completed
- Conditions
- Melanoma
- First Posted Date
- 2019-05-09
- Last Posted Date
- 2025-03-12
- Lead Sponsor
- EuMelaReg gGmbH
- Target Recruit Count
- 232
- Registration Number
- NCT03944356
- Locations
- 🇩🇪
Universitätsklinikum Essen, Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie, Essen, Nordrhein-Westfalen, Germany
🇩🇪Elbe Kliniken Stade - Buxtehude GmbH, Buxtehude, Niedersachsen, Germany
🇩🇪Katholisches Klinikum Bochum, Bochum, Germany
© Copyright 2025. All Rights Reserved by MedPath